title: Early treatment of endometriosis with GnRH-agonists: impact on time to recurrence.
abstract: In a study, 52 patients with histologically confirmed endometriosis underwent a "three-step" therapy. The follow-up period was up to 60 months (median 33.5 months). If r-AFS-score was posttherapeutically 0, recurrence occurred latest after 36 months (median 18 months), if stage III was found posttherapeutically, recurrence occurred already latest after 18 months (median 8 months), (log-rank test P=0.0072). In our study we could confirm a clear relationship of recurrence of symptomatic endometriosis to the post-therapeutically achieved r-AFS-score.
authors.affiliation: Department of Gynaecology of the University of Essen, Hufelandstrasse 55, D-45147 Essen, Germany.
authors.forename: A E
authors.initials: AE
authors.lastname: Schindler
authors.forename: P
authors.initials: P
authors.lastname: Foertig
authors.forename: E
authors.initials: E
authors.lastname: Kienle
authors.forename: P A
authors.initials: PA
authors.lastname: Regidor
mesh_terms: D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence; D013997:Time Factors
chemical_list: D007987:Gonadotropin-Releasing Hormone